Department of Pharmacy, China-Japan Friendship Hospital, Beijing, China.
Department of Pharmacology, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Yinghua Donglu, Hepingli, Chaoyang District, Beijing 100029, China.
J Ethnopharmacol. 2015 May 26;166:31-41. doi: 10.1016/j.jep.2015.02.019. Epub 2015 Feb 17.
Chaihuang-Yishen formula (CHYS) is a Chinese herbal formula that has been shown clinically to effectively treat chronic kidney disease including diabetic nephropathy (DN), also known as diabetic kidney disease. Our previous animal studies showed that numerous intrarenal metabolites were associated with the development of DN. In the present work, an integrated metabolomic and lipidomic analysis was used to further examine whether CHYS could attenuate the development of DN by regulating the disordered metabolic pathways.
Progressive diabetic kidney disease was induced in Wistar rats by uninephrectomy and a single intraperitoneal injection of streptozocin. Over 20 weeks, one group of animals was treated with CHYS and another group went untreated. Effects of CHYS on metabolomic and lipidomic changes in the renal cortex of diabetic rats were studied using gas chromatography/time-of-flight mass spectrometry, ultra-performance liquid chromatography/time-of-flight mass spectrometry, and tandem MS-based metabolomic and lipidomic. The well-established drug fosinopril was used as positive control throughout the experiment.
Like fosinopril, treatment with CHYS produced a renoprotective effect against DN. Metabolomic and lipidomic analyses showed that the therapeutic effect of CHYS on DN was significantly associated with inhibition of the elevated organic toxins including several uremic toxins and glucuronides, and normalization of diminished phospholipids, especially sphingomyelins.
Improved abnormal metabolic and lipidomic disorders, such as accumulation of uremic toxins and glucuronides and phospholipids, may be mechanisms by which treatment of CHYS inhibits DN. Results from this study provide new evidence for the pharmacologic characteristics of CHYS on DN.
柴黄益肾方(CHYS)是一种中药方剂,临床上已证明其能有效治疗慢性肾病,包括糖尿病肾病(DN),也称为糖尿病肾病。我们之前的动物研究表明,许多肾内代谢物与 DN 的发生有关。在本研究中,采用整合代谢组学和脂质组学分析方法,进一步研究 CHYS 是否通过调节紊乱的代谢途径来减轻 DN 的发展。
通过单侧肾切除术和单次腹腔注射链脲佐菌素,在 Wistar 大鼠中诱导进行性糖尿病肾病。在 20 周的时间里,一组动物用 CHYS 治疗,另一组动物未治疗。采用气相色谱/飞行时间质谱、超高效液相色谱/飞行时间质谱和基于串联质谱的代谢组学和脂质组学研究 CHYS 对糖尿病大鼠肾皮质代谢组学和脂质组学变化的影响。整个实验过程中,均使用已确立的药物福辛普利作为阳性对照。
与福辛普利一样,CHYS 治疗对 DN 具有肾保护作用。代谢组学和脂质组学分析表明,CHYS 对 DN 的治疗效果与抑制升高的有机毒素(包括几种尿毒症毒素和葡萄糖醛酸苷)显著相关,并使减少的磷脂(特别是神经鞘磷脂)正常化。
改善尿毒症毒素和葡萄糖醛酸苷以及磷脂等异常代谢和脂质紊乱可能是 CHYS 抑制 DN 的作用机制。本研究结果为 CHYS 对 DN 的药理特性提供了新的证据。